About 100 million people worldwide suffer from chronic ulcers, one third of which are diabetic foot ulcers. If treatment fails, the patient may lose a limb or even his life. The business network created within the framework of this project will help Nanordica bring its new type of wound dressing to patients both in Europe and the USA. 

The project is financed from the state budget through funding for research and development activities.